End-to-End Continuous API & Drug Product Manufacturing — OEM
Continuus Pharma, a spinout from a multi-year collaboration between Novartis and MIT, developed the first fully integrated, end-to-end continuous API and drug product manufacturing technology platform capable of reducing lead times for drug product supply from more than a year to days. Despite this, CapEx required to build out continuous lines at GMP scale is daunting to companies. Paired with general industry inertia and fear of change, Continuus needed to implement a GTM strategy to educate audiences on the benefits of its tech.
Developed a brand and message to convey the transformative power of Continuus’s platform and its potential to deliver life-changing medicines at lower cost and at greater speeds.
Communicated Continuss’s value proposition to the market.
